Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.1M Sell
2,984
-41
-1% -$14K 0.02% 357
2026
Q1
$1.07M Buy
3,025
+1,008
+50% +$359K 0.02% 347
2025
Q4
$660K Buy
2,017
+193
+11% +$61.2K 0.01% 316
2025
Q3
$540K Buy
1,824
+51
+3% +$14.8K 0.01% 317
2025
Q2
$519K Buy
1,773
+440
+33% +$125K 0.01% 289
2025
Q1
$388K Buy
1,333
+48
+4% +$14.2K 0.01% 276
2024
Q4
$335K Buy
1,285
+3
+0.2% +$890 0.01% 274
2024
Q3
$410K Buy
1,282
+54
+4% +$17.7K 0.02% 234
2024
Q2
$388K Buy
1,228
+45
+4% +$13.2K 0.02% 228
2024
Q1
$320K Sell
1,183
-87
-7% -$25.5K 0.02% 239
2023
Q4
$385K Sell
1,270
-602
-32% -$164K 0.02% 208
2023
Q3
$503K Buy
1,872
+600
+47% +$150K 0.04% 169
2023
Q2
$282K Buy
+1,272
New +$295K 0.02% 222
2022
Q4
$344K Buy
1,310
+156
+14% +$41.8K 0.03% 179
2022
Q3
$260K Buy
1,154
+37
+3% +$8.97K 0.03% 186
2022
Q2
$272K Buy
+1,117
New +$274K 0.03% 187
2021
Q3
Sell
-1,045
Closed -$255K 200
2021
Q2
$255K Buy
1,045
+3
+0.3% +$738 0.04% 183
2021
Q1
$259K Buy
1,042
+3
+0.3% +$716 0.08% 115
2020
Q4
$239K Sell
1,039
-427
-29% -$98.4K 0.08% 116
2020
Q3
$373K Hold
1,466
0.15% 91
2020
Q2
$346K Hold
1,466
0.16% 94
2020
Q1
$297K Buy
+1,466
New +$320K 0.17% 85

Other funds holding AMGN

Apella Capital's AMGN Position: Q2 2026 in Review

Apella Capital reduced its Amgen (AMGN) stake by 1.4% in Q2 2026, selling an estimated $14K and leaving 2,984 shares worth $1.1M. The position accounts for 0.02% of the portfolio, ranked #357.

Apella Capital first reported a position in AMGN in Q1 2020 and has held it in 22 quarters since. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Apella Capital held 2,984 shares of Amgen worth $1.1M as of Q2 2026.
  • Apella Capital sold 41 Amgen shares in Q2 2026, an estimated $14K.
  • Amgen made up 0.02% of Apella Capital's portfolio in Q2 2026, its #357 holding.
  • Apella Capital first reported a position in Amgen in Q1 2020 and has held it in 22 quarters since.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Apella Capital's 13F filing for Q2 2026, filed 8 Jul 2026.